sobycombi tablett
krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 5mg+10mg 28tk; 5mg+10mg 84tk; 5mg+10mg 56tk; 5mg+10mg 90tk; 5mg+10mg 60tk
sobycombi tablett
krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 10mg+5mg 56tk; 10mg+5mg 84tk
sobycombi tablett
krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 5mg+5mg 30tk; 5mg+5mg 84tk; 5mg+5mg 56tk; 5mg+5mg 90tk; 5mg+5mg 28tk; 5mg+5mg 60tk
sobycombi tablett
krka, d.d., novo mesto - bisoprolool+amlodipiin - tablett - 10mg+10mg 60tk; 10mg+10mg 90tk; 10mg+10mg 30tk; 10mg+10mg 28tk; 10mg+10mg 56tk
candisil hct tablett
laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 16mg+12,5mg 56tk; 16mg+12,5mg 100tk; 16mg+12,5mg 14tk; 16mg+12,5mg 300tk; 16mg+12,5mg 7tk; 16mg+12,5mg 15tk
candisil hct tablett
laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 8mg+12,5mg 30tk; 8mg+12,5mg 100tk; 8mg+12,5mg 56tk; 8mg+12,5mg 98tk
candisil hct tablett
laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 32mg+12,5mg 28tk; 32mg+12,5mg 56tk; 32mg+12,5mg 50tk; 32mg+12,5mg 15tk; 32mg+12,5mg 100tk
candisil hct tablett
laboratorios liconsa s.a. - kandesartaan+hüdroklorotiasiid - tablett - 32mg+25mg 7tk; 32mg+25mg 300tk; 32mg+25mg 100tk; 32mg+25mg 15tk; 32mg+25mg 56tk; 32mg+25mg 98tk
elonva
n.v. organon - korifollitropiin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - suguhormoonid ja genitaalsüsteemi, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol dietüülfumaraat dihüdraat, glycopyrronium bromiid - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.